新規登録 | ログイン | FAQ      [?] 

Expert Opinion on Therapeutic Targets

最近発刊の雑誌の目次より: Expert Opinion on Therapeutic Targets © Informa Healthcare
  • Relationship between plasma osteopontin and oxidative stress in patients with coronary artery disease
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 8. (August 2008), pp. 917-920.
    by Boudoulas, , Georgiadou, , Iliodromitis, Ek, Varounis, , Mavroidis, , Kolokathis, , Andreadou, , Psarras, , Capetanaki, , Kremastinos, D Th
  • MK2: a novel molecular target for anti-inflammatory therapy
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 8. (August 2008), pp. 921-936.
    by Duraisamy, Senthil, Bajpai, Malini, Bughani, Usha, Dastidar, G Sunanda, Ray, Abhijit, Chopra, Puneet
  • Cholesterol ester transfer protein: a therapeutic target in atherosclerosis?
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 8. (August 2008), pp. 937-948.
    by Vourvouhaki, Ekaterini, Dedoussis, V George
  • Treatment of autism spectrum disorders: neurotransmitter signaling pathways involved in motivation and reward as therapeutic targets
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 8. (August 2008), pp. 949-967.
    by Walker, A Michael
  • Signaling through CD80: an approach for treating lymphomas
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 8. (August 2008), pp. 969-979.
    by Mir, A Manzoor, Agrewala, N Javed
  • IAPs as therapeutic targets in haematological malignancies
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 8. (August 2008), pp. 981-993.
    by Langemeijer, C Sm, De Graaf, Ao, Jansen, Jh
  • Netrin-1 and its receptors in tumour growth promotion
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 8. (August 2008), pp. 995-1007.
    by Bernet, Agnes, Fitamant, Julien
  • Downregulating sphingosine kinase-1 for cancer therapy
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 8. (August 2008), pp. 1009-1020.
    by Cuvillier, Olivier
  • Grb2 signaling in cell motility and cancer
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 8. (August 2008), pp. 1021-1033.
    by Giubellino, Alessio, Burke, R Terrence, Bottaro, P Donald
  • DNA methylation: A promising target for the twenty-first century
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 8. (August 2008), pp. 1035-1047.
    by Abreu, A Paula, Dellamora-Ortiz, Gisela, Leao-Ferreira, R Luiz, Gouveia, Maria, Braggio, Esteban, Zalcberg, Ilana, Santos, O Dilvani, Bourguinhon, Saulo, Cabral, M Lucio, Rodrigues, R Carlos, Castro, C Helena
  • PPAR- signaling pathway in placental development and function: A potential therapeutic target in the treatment of gestational diseases
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 8. (August 2008), pp. 1049-1063.
    by Giaginis, Costas, Spanopoulou, Evangelia, Theocharis, Stamatios
  • Use of LHRH-agonists as adjuvant therapy for breast cancer
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 8. (August 2008), pp. 1065-1071.
    by Cuzick, Jack
  • The effects of pharmacological PAI-1 inhibition on thrombus formation and neointima formation after arterial injury
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 7. (July 2008), pp. 783-794.
    by Suzuki, Jun-Ichi, Ogawa, Masahito, Muto, Susumu, Yamaguchi, Yoichi, Itai, Akiko, Isobe, Mitsuaki
  • MAPK phosphatases as novel targets for rheumatoid arthritis
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 7. (July 2008), pp. 795-808.
    by Ralph, A Jennifer, Morand, F Eric
  • Established and emerging vascular risk factors and the development of aortic stenosis: an opportunity for prevention?
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 7. (July 2008), pp. 809-820.
    by Tziomalos, Konstantinos, Athyros, G Vasilios, Karagiannis, Asterios, Mikhailidis, P Dimitri
  • Molecular diagnosis of the viral component in cardiomyopathies: pathophysiological, clinical and therapeutic implications
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 7. (July 2008), pp. 821-836.
    by Halapas, , Pissimissis, , Lembessis, , Rizos, , Rigopoulos, Ag, Kremastinos, Dt, Koutsilieris,
  • Eag1 as a cancer target
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 7. (July 2008), pp. 837-843.
    by Pardo, A Luis, Suhmer, Walter
  • Potential role of EPB41L3 (Protein 4.1B/Dal-1) as a target for treatment of advanced prostate cancer
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 7. (July 2008), pp. 845-853.
    by Bernkopf, B Dominic, Williams, D Elizabeth
  • Molecular targeting of E3 ligases a therapeutic approach for cancer
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 7. (July 2008), pp. 855-870.
    by Lakshmanan, Manikandan, Bughani, Usha, Duraisamy, Senthil, Diwan, Manish, Dastidar, Sunanda, Ray, Abhijit
  • From hyperglycemia to AGE-RAGE interaction on the cell surface: A dangerous metabolic route for diabetic patients
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 7. (July 2008), pp. 871-882.
    by Nogueira-Machado, Jose Augusto, Chaves, Miriam Martins
  • Kinase inhibitors as drugs for chronic inflammatory and immunological diseases: progress and challenges
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 7. (July 2008), pp. 883-903.
    by Rokosz, L Laura, Beasley, R James, Carroll, Carolyn Diianni, Lin, Tsung, Zhao, Jiuqiao, Appell, C Kenneth, Webb, L Maria
  • Rogue proliferation versus restorative protection: Where do we draw the line for Wnt and Forkhead signaling?
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 7. (July 2008), pp. 905-916.
    by Maiese, Kenneth, Chong, Zhao Zhong, Shang, Yan Chen, Hou, Jinling
  • Initiation of protein synthesis: a target for antimicrobials
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 5. (May 2008), pp. 519-534.
    by Brandi, Letizia, Fabbretti, Attilio, Pon, L Cynthia, Dahlberg, E Albert, Gualerzi, O Claudio
  • Protein kinase C isozymes as potential therapeutic targets in immune disorders
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 5. (May 2008), pp. 535-552.
    by Lee, R Matthew, Duan, Wei, Tan, Seng-Lai
  • Novel therapeutic targets in the treatment of IBD
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 5. (May 2008), pp. 553-563.
    by Kaser, Arthur, Tilg, Herbert
  • The therapeutic potential of neuronal KV7 (KCNQ) channel modulators: an update
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 5. (May 2008), pp. 565-581.
    by Gribkoff, K Valentin
  • Upregulating substance P levels to treat obstructive sleep apnea
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 5. (May 2008), pp. 583-588.
    by Ursavas, Ahmet
  • Targeting the type 1 insulin-like growth factor receptor as a treatment for cancer
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 5. (May 2008), pp. 589-603.
    by Yuen, SP John, Macaulay, M Valentine
  • Targeting of extracellular proteases required for the progression of pancreatic cancer
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 5. (May 2008), pp. 605-619.
    by Ardito, M Christine, Briggs, D Courtney, Crawford, C Howard
  • Chemokines and antagonists in non-Hodgkin's lymphoma
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 5. (May 2008), pp. 621-635.
    by Golay, Josee, Introna, Martino
  • Small interfering RNA therapy in cancer: mechanism, potential targets, and clinical applications
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 5. (May 2008), pp. 637-645.
    by Huang, Chuan, Li, Min, Chen, Changyi, Yao, Qizhi
  • The P2X7 receptor as a therapeutic target
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 5. (May 2008), pp. 647-661.
    by Romagnoli, Romeo, Baraldi, Pier Giovanni, Cruz-Lopez, Olga, Lopez-Cara, Carlota, Preti, Delia, Borea, Pier Andrea, Gessi, Stefania
  • Identifying targets for drug discovery using bioinformatics
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 4. (April 2008), pp. 383-389.
    by Phoebe Chen, Yi-Ping, Chen, Feng
  • New therapeutic targets in immune disorders: ItpkB, Orai1 and UNC93B
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 4. (April 2008), pp. 391-413.
    by Huang, H Yina, Hoebe, Kasper, Sauer, Karsten
  • Cysteinyl leukotriene receptor CysLT1 as a novel therapeutic target for allergic rhinitis treatment
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 4. (April 2008), pp. 415-423.
    by Shirasaki, Hideaki
    posted by 1 person YamaPing
  • Potential therapeutic targets for Parkinson's disease
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 4. (April 2008), pp. 425-436.
    by Stoessl, Jon
  • Neurotrophic factors as a therapeutic target for Parkinson's disease
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 4. (April 2008), pp. 437-447.
    by Evans, R Jonathan, Barker, A Roger
  • Therapeutic targets for medulloblastoma
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 4. (April 2008), pp. 449-461.
    by Wlodarski, K Pawel, Jozwiak, Jaroslaw
  • Targeting survivin in cancer therapy
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 4. (April 2008), pp. 463-476.
    by Pennati, Marzia, Folini, Marco, Zaffaroni, Nadia
  • Targeting the TCR signaling checkpoint: a therapeutic strategy to reactivate memory T cells in the tumor microenvironment
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 4. (April 2008), pp. 477-490.
    by Simpson-Abelson, Michelle, Bankert, B Richard
    posted by 1 person eisei
  • ABCA2 as a therapeutic target in cancer and nervous system disorders
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 4. (April 2008), pp. 491-504.
    by Mack, T Jody, Brown, B Carol, Tew, D Kenneth
  • The yeast two-hybrid system and its role in drug discovery
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 4. (April 2008), pp. 505-515.
    by Lentze, Nicolas, Auerbach, Daniel
    posted by 1 person higueruelo
  • Anti-infectives Targeting the isoprenoid pathway of Toxoplasma gondii
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 3. (March 2008), pp. 253-263.
    by Moreno, NJ Silvia, Li, Zhu-Hong
  • Nuclear factor kappa B and hepatitis viruses
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 3. (March 2008), pp. 265-280.
    by Guan, Yong-Song, He, Qing, Wang, Ming-Quan, Li, Ping
  • Intracellular immune dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome: state of the art and therapeutic implications
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 3. (March 2008), pp. 281-289.
    by Nijs, Jo, Fremont, Marc
  • Cysteine cathepsin S as an immunomodulatory target: present and future trends
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 3. (March 2008), pp. 291-299.
    by Gupta, Suman, Singh, Rakesh Kumar, Dastidar, Sunanda, Ray, Abhijit
  • Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 3. (March 2008), pp. 301-312.
    by Mitsuyama, Keiichi, Sata, Michio
  • CD4CD25 regulatory T cells: a therapeutic target for liver diseases
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 3. (March 2008), pp. 313-326.
    by Zheng, Ming-Hua, Gu, Dian-Na, Braddock, Martin, Leishman, J Andrew, Jin, Chang, Wen, Jin-Sheng, Gong, Yue-Wen, Chen, Yong-Ping
  • Therapeutic targets in hypertension: is there a place for antagonists of the most potent vasoconstrictors?
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 3. (March 2008), pp. 327-339.
    by Giachini, RC Fernanda, Callera, E Glaucia, Carneiro, S Fernando, Tostes, C Rita, Webb, R Clinton
  • CD70 as a therapeutic target in human malignancies
    Expert Opinion on Therapeutic Targets, Vol. 12, No. 3. (March 2008), pp. 341-351.
    by Grewal, S Iqbal
    • 注: このページを引用する時は次のURLでどうぞ: http://www.citeulike.org/journal/apl-ett

    Result page: 1 2 3 4 5 6 7 8 Next RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.